These data support a tumour-suppressive role for chondroadherin, suggesting that it may inhibit breast tumour progression by stabilizing cell–matrix interactions and restraining oncogenic PI3K/Akt signalling activity. The gene discussed is CHAD; the disease is neoplasm.